Molecular Biometrics

About:

Molecular Biometrics applies metabolomic technologies to develop non-invasive methodologies for evaluating biologic function in health.

Website: http://www.molecularbiometrics.com

Top Investors: Atlas Venture, Safeguard Scientifics, Oxford Bioscience Partners

Description:

Molecular Biometrics, Inc., is applying novel metabolomic technologies to develop accurate, non-invasive methodologies for evaluating normal biologic function in health and disease, and for drug discovery and development. The company's proprietary technology is being applied in reproductive health, neurodegenerative disease (Alzheimer's disease and Parkinson's disease), maternal fetal medicine, pulmonary metabolism and edema, and lactate metabolism.

Total Funding Amount:

$24.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Norwood, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)molecularbiometrics.com

Founders:

Hyman Schipper

Number of Employees:

11-50

Last Funding Date:

2010-01-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai